Angela She

Angela oversees R&D operations, including program and alliance management at Viridian. Prior to joining Viridian in 2020, she worked within the Flagship Pioneering portfolio driving innovation in the startup biotech sphere by establishing and developing R&D strategy, and program and portfolio management capabilities, as well as leading multiple autoimmune therapeutics programs. 

Angela holds a Ph.D. in Chemical Biology from Harvard University and a B.S. in Chemistry from Yale University.